VERICEL CORPORATION - COMMON STOCK
N/A
31-12月-69 19:00:00
15 分の遅延
株式
N/A
本日の幅
N/A - N/A
ISIN
N/A
ソース
NASDAQ
-
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
25 10 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
28 9 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
20 9 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
Vericel to Present at the Morgan Stanley Global Healthcare Conference
06 9 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
02 8 2023 07:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
20 7 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
10 5 2023 07:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023
26 4 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023
28 2 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
23 2 2023 07:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023
09 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
10 1 2023 07:55:00 提供 Nasdaq GlobeNewswire
-
04 1 2023 08:34:47 提供 Nasdaq GlobeNewswire
-
Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults
29 12 2022 13:45:00 提供 Nasdaq GlobeNewswire
-
10 11 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
Vericel Reports Third Quarter 2022 Financial Results
09 11 2022 07:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022
26 10 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
Vericel to Present at the Ladenburg Thalmann Healthcare Conference
22 9 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
06 9 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
Vericel Reports Second Quarter 2022 Financial Results
03 8 2022 07:55:00 提供 Nasdaq GlobeNewswire